GlassScriptPhysician profile
Shivani Ruben
NPI 1770928954
$2,862.11
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $1,423 · 2021: $128 · 2022: $253.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,127.50 | 2019-2020 | |
| Novo Nordisk INC | $364.38 | 2019-2022 | |
| Pfizer INC. | $67.35 | 2019 | |
| Allergan, INC. | $66.99 | 2019-2020 | |
| Amgen INC. | $40.22 | 2019 | |
| Merck Sharp & Dohme LLC | $35.47 | 2019 | |
| Abbvie INC. | $30.19 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.79 | 2019-2020 | |
| Corcept Therapeutics | $20.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.15 | 2019 | |
| Glaxosmithkline, LLC. | $13.64 | 2020 | |
| Amarin Pharma, INC. | $11.33 | 2019 | |
| Fidia Pharma USA INC. | $5.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivani Ruben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.